Diabetes Drugs Come with Amputation Risk

Diabetes Drugs Come with Amputation Risk | Pintas & Mullins Law Firm
Despite concerns about heart health and bone safety, Invokana and Invokamet, new medicines for type 2 diabetes, remain on the market. The FDA recently added its most severe warning to these drugs for increased risk of toe, foot, and leg amputation.

WHY ARE THESE MEDICATIONS PRESCRIBED?

Type 2 diabetes patients’ bodies don’t produce enough insulin naturally, causing blood sugar to skyrocket. If this condition goes untreated, life-threatening issues like heart disease, nerve damage, and blindness can develop.

Doctors prescribe Invokana and Invokamet to lower blood sugar levels and help the kidneys get rid of sugar in urine. These medications don’t cure type 2 diabetes; they just help the body control it.

A recent study about Invokana and Invokamet found that patients who use them are twice as likely to have a part of their leg amputated than patients who took a placebo drug. Amputations are especially probable for patients with prior amputations, peripheral vascular disease (PVD), neuropathy, or diabetic foot ulcers.

WHAT TO LOOK FOR

Patients who must take Invokana or Invokamet should do so with caution. Health care professionals should be contacted immediately if a patient experiences these symptoms in the legs or feet:

•             Pain or tenderness

•             Sores or ulcers

•             Infections

Related: FDA Strengthens Invokana and Invokamet Warnings

WE ARE HERE TO HELP YOU

The Invokana and Invokamet attorneys at Pintas & Mullins Law Firm are currently investigating cases of leg or foot amputations after taking Invokana and Invokamet. Call our firm today with any questions or concerns – we practice nationwide and can travel to you for a free consultation.

CATEGORIES